Biotechnology in Europe
Summary
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The European biotechnology industry had total revenues of $63.6bn in 2016, representing a compound annual growth rate (CAGR) of 5.7% between 2012 and 2016.
- The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $40.3bn, equivalent to 63.4% of the industry's overall value.
- This acceleration will be driven by Germany which will overtake the UK as the leading biotechnology industry in Europe by 2021.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Europe biotechnology market by value in 2016?
- What will be the size of the Europe biotechnology market in 2021?
- What factors are affecting the strength of competition in the Europe biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's biotechnology market?
